 - Significant systemic or major illnesses other than liver disease, including congestive heart failure class C and D of the American Heart Association , AHA, unstable coronary artery disease, cerebrovascular disease, pulmonary disease, renal failure, organ transplantation, serious psychiatric disease, malignancy that, in the opinion of the investigator, would preclude treatment with IVA337 andor adequate follow up. 